Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyzed Asymmetric Allylic Alkylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115093323B enables efficient iridium-catalyzed synthesis of beta-functionalized chiral homoallylic alcohols. Delivers high enantioselectivity and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN114105822A reveals high-yield iridium-catalyzed synthesis of pseudo-C2 symmetric chiral diallyl compounds, offering superior enantioselectivity for pharmaceutical and agrochemical manufacturing.